Dr. Jamison Derek Feramisco, MD, PhD

Dr. Feramisco practices at Colusa Medical Center Home Health in Colusa, California.

Dr. Feramisco's NPI, 1043410871, was assigned on July 19, 2007. Dr. Feramisco graduated from UT Southwestern Medical Center in 2007. Dr. Feramisco holds California license A105161.

Dr. Feramisco's primary practice is Colusa Medical Center Home Health, at 199 E Webster Street, Colusa, CA 95932. The practice phone is (530) 619-0800.

Dr. Feramisco's primary practice is Colusa Medical Center Home Health in Colusa, California. Dr. Feramisco is also affiliated with Colusa Medical Center. The medical group on file is Family Health Centers of San Diego. Dmand AI also links Dr. Feramisco to 1 more hospital, 7 medical groups, 3 skilled nursing facilities, 2 group practices and clinics, 2 home health agencies and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feramisco practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Feramisco's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Feramisco's licenses on file in 6 states: California, Florida, New York, Hawaii, North Carolina and Oregon.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, hives, itchy rashes and psoriasis among the conditions Dr. Feramisco treats.

CMS data shows 56,596 Medicare services from Dr. Feramisco across 41 procedure codes in 2024, for 2,736 Medicare patients. Medicare paid $19,905,808 for them.

CMS counts 2,736 Medicare patients who saw Dr. Feramisco in 2024. The largest group is 75 to 84, with 879 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 74% are also on Medicaid. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feramisco's median patient age at 65, with 59% women.

In 2024, Dr. Feramisco wrote 18,631 Medicare Part D claims for 1,049 patients. 81% of them were for generic drugs. CMS names the drug for 17,710 of them, across 224 drugs with 11 or more claims each, at $1,347,466 in total drug cost. In 2023, CMS named 19,322 claims across 249 drugs.

Dr. Feramisco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feramisco as offering telehealth. CMS counts 3,854 procedures of removal of tissue by Dr. Feramisco, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Feramisco, published from 2003 to 2014. 2009 was the busiest year, with 2. The most frequent topics are Intracellular Signaling Peptides and Proteins, Membrane Proteins and Amino Acid Sequence. Dr. Feramisco has published most often in J Biol Chem. Dr. Feramisco's most frequent co-authors are Joseph Leonard Goldstein, MD, Lindy P. Fox, MD and Christopher M. Adams, MD, PhD.

CMS Open Payments shows 36 general payments to Dr. Feramisco from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 96% of the total. Haemonetics Corporation paid the most, $77,825.

Dr. Feramisco graduated from UT Southwestern Medical Center in 2007.

Dr. Feramisco is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.